chrisvoncsefalvay/vaers-outcomes huggingface dataset:
seasonal allergies; she received her first dose of the Pfizer BioNTech COVID-19 vaccine on 23MAR2021 and reports that this past Sunday on 4APR2021 she tested positive for COVID-19; This is a spontaneous report from a contactable consumer (patient). A 24-years-old female patient received bnt162b2 (BNT162B2), dose 1 via an unspecified route of administration, administered in Arm Left on 23Mar2021 11:00 (Batch/Lot Number: ER2613; Expiration Date: Jul2021) as SINGLE DOSE for covid-19 immunisation.  Medical history included none.  There were no concomitant medications reported. It was reported that patient received her first dose of the Pfizer BioNTech COVID-19 vaccine on 23Mar2021 and reports that this past Sunday on 04Apr2021 she tested positive for COVID-19. Caller states she did have an exposure at work and knows that she got COVID-19 from someone she works with. She states that she is in her 10 day quarantine currently and heard that she has to be retested and have 2 negative tests. Caller would like to know when she would be able to get her second dose of the vaccine. She mentions possibly having to cancel her second dose appointment at this time. She knows she had the Covid 19 exposure from someone at work. She had no side effects with the Covid 19 vaccine except for a sore arm the first day. Her sore arm only lasted 24 hours. Friday, 02Apr2021, she started having cold like symptoms. Friday was her worst day. Every day has been getting better. She started off having a runny nose but she has seasonal allergies so she thought her runny nose was related to her seasonal allergies. She used to take Allegra every day and she was really good at taking it. She thought it was a continuation of her allergies. She did take Benadryl 2-3 tablets throughout Friday. She had chills, a headache and a potential fever. She didn't actually check her temperature for a fever. She had the runny nose and a cough. The patient underwent lab tests and procedures which included sars-cov-2 test: positive on 04Apr2021. Outcome of the events was unknown.
Patient states arm very swollen and red day after receiving. Got increasingly worse - and tingling up to 1 month after. I reached out to MD, they were going to call patient to schedule appointment to evaluate.
pt recvd vax;devel thrombocytopenic purpura;exp also an acute onset of escherichia coli 0157:H7 infection complicated by pseudomembranous colitis;died 7 days following vax;
Initial report received on 1/30/2006 from the patients parent. A 38 year old female patient with a history of pericarditis and insulin dependent diabetes had received an administration (route not reported) of Fluzone SV 2005-2006 USP lot number not reported, in the left arm, and an administration route not reported, of another manufacturers Pneumovax 23 vaccine, lot number not reported in the left arm on 11/03/2005. that same day the patient developed chest and shoulder pain. the patient was uncomfortable for three weeks and on 12/16/2005 she began to experienced shortness of breath. The chest pain became more severe on 12/28/2005 and the patient was seen in the ER. per the reporter, the patient had high ketoacidosis, WBC and a 0.38 cardiac enzyme. An Echo, EKG and cat scan was completed (date and results not reported). At the time of this report the patient had not recovered from these events. - Per review of medical records on 4/13/06 the diagnoses were hyperglycemia, dyspnea, and elevated troponin (0.38). Leukocytosis was later noted and was thought to be secondary to the elevated blood glucose. Admission list of diagnoses included diabetic ketoacidosis, possible sinusitis, hypothyroidism, shortness of breath (likely secondary to metabolic acidosis), and history of tobacco abuse (down to 1 PPD from 2PPD). Malaise and periorbital swelling were noted on PE. 4/13/06 Review of medical records for 3/23/06 overnight ER admission indicates discharge diagnoses of fever, abdominal pain, and chest pain.  Per 60 day follow up recipient has not recovered yet has elevated white blood count, fevers of 100.1-100.6 and shortness of breath episodes.  Follow-up: High white blood count. Elevated neutrophils. Low grade fever. Burning in chest area. All since 11-3-05.
03-31-2021 COVID-19 PCR POSITIVE, PT REPORTS SINUS PRESSURE, TIRED, DECREASED ENERGY AND LIGHT HEADED. PT STATES HE COMPLETED THE COVID-19 VACCINE SERIES. PRIME DOSE 12-30-2020 AND BOOSTER DOSE 01-20-2021.
Large red welt and soreness at injection site lasting for 7 days.  Fatigue, muscle and joint pain, fever, chills, nausea, for 2 days. Treated with Tylenol.
Severe pain in my right arm if I moved it at all. The pain started 6 hours after I received the injection. I put an ice pack on my arm that evening and during the night to get some relief. The next morning I had a red spot the size of an orange. I had a fever and my arm was hot to touch. I was still in pain but not as severe as the night before. I called the doctor's office. When I first called my doctor's office, the nurse told me everything I told her was normal. She said she would talk to the doctor. When the nurse finally got back to me, I was told to rub the area because the medicine hadn't been absorbed and then put heat on it. I did this. The red then started covering my entire arm and extended down to my elbow. I was still in pain. I had a physical therapy appointment on Thursday afternoon for the rotator cuff tear in my left shoulder. I couldn't do very many exercises because I couldn't move my left arm. When the therapist saw how red and hot my right arm was and that my doctor's office wasn't concerned, she was upset. She told me I really needed to call. I called the office as soon as I left. My doctor isn't in on Thursday afternoon and his nurses were gone. The office said there was no one else who could see me. I called the nurse help line offered through my insurance. She was very concerned and thought I might have cellulitis. She told me to go to a prompt care immediately. The nurse practitioner at the prompt care said it was not cellulitis. She did not think I reacted to the serum but something in the shot. She told me to continue heat. I did this but by Friday night my arm was very red and sore. I started to apply ice again and the red started to go away. The pain and soreness finally left in a week. I still have a discoloring the size of an orange where the original red spot was. My dermatologist thinks it may be a reaction from adhesive from the ice pack.
On Friday morning began suffering horribly with retching vomiting, brief periods of unconsciousness, and complete incontinence. Awoke Saturday morning with numbness on whole left side of body. Called Dr. and he advised go to ER immediately. Went to Hospital ER and they diagnosed a very small Lacunar stroke had occurred (ran MRI of brain). Prescribed 81mg Aspirin regimen and directed to follow-up with a Neurologist (a doctor's name and facility was provided. Made appointment and will see Dr. on 4/15/21.
severe body aches; Fatigue; chills; This is a spontaneous report from a non-contactable Other HCP. This 54-year-old female Other HCP (patient) received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE) (lot number: Ek4176/expiration date: unknown), via an unspecified route of administration, on 16Jan2021 09:30 AM (at the age of 54 years old) as a single dose on left arm for COVID-19 immunisation at a hospital facility. Relevant medical history was none. Historical vaccine history included first dose of BNT162B2 vaccine (Pfizer product) on 31Dec2020 (lot number: EL0140) on left arm. The patient did not have any known allergies to medications, food, or other products. Patient was not pregnant at time of vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications were not provided. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. On 16Jan2021 08:30 PM, the patient stated that approximately 12 hours after 2nd dose, she experienced severe body aches, fatigue, chills lasting approximately 20 hours.  The outcome of the events severe body aches, fatigue, chills was recovered.   No follow-up attempts are possible. No further information is expected.
partial paralyzed weak legs; Initial information was received on 25-Oct-2021 regarding an unsolicited valid serious case received from a consumer/non-health care professional via Social Media.  This case involves a female patient of unknown date who had partial paralyzed weak legs (Paraparesis) after receiving INFLUENZA VACCINE.  The patient's medical history, medical treatment(s), concomitant therapy, vaccination(s) and family history were not provided.  On an unknown date, the patient received a dose of suspect INFLUENZA VACCINE produced by unknown manufacturer (lot number and expiry date not reported) via an unknown route in unknown administration site for prophylactic vaccination.  On an unknown date, the patient had partial paralyzed weak legs (Paraparesis; serious) (unknown latency) following the administration of INFLUENZA VACCINE. These events were assessed as medically significant and patient visited the emergency room  for these events.  It was unknown if the patient experienced any additional symptoms/events.  Reporter stated she was very much adamant not to get flu shot.  Details of laboratory data were not reported.  It was not reported if the patient received any corrective treatment for the events.  On an unknown date, patient had recovered from the events.  Information on the batch number was requested.; Sender's Comments: This case concerns a female patient of unknown age who experienced partial paralyzed weak legs (Paraparesis)after vaccination with INFLUENZA VACCINE (unknown manufacturer). The time to onset was unknown. Additional information regarding medical history, condition at the time of vaccination and lab data excluding other predisposing etiologies would be needed for complete assessment of the case. Based upon the reported information, the role of the suspect vaccine cannot be assessed.
Develop a circular red rash on the arm of the vaccination; Itchy area on arm; Pain on the arm of the vaccination; This spontaneous case was reported by a consumer and describes the occurrence of RASH ERYTHEMATOUS (Develop a circular red rash on the arm of the vaccination), PRURITUS (Itchy area on arm) and PAIN IN EXTREMITY (Pain on the arm of the vaccination) in a 40-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 024C21A) for COVID-19 vaccination.     No medical history and concomitant drug information provided by reporter.     On 14-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 15-May-2021, the patient experienced RASH ERYTHEMATOUS (Develop a circular red rash on the arm of the vaccination), PRURITUS (Itchy area on arm) and PAIN IN EXTREMITY (Pain on the arm of the vaccination). At the time of the report, RASH ERYTHEMATOUS (Develop a circular red rash on the arm of the vaccination), PRURITUS (Itchy area on arm) and PAIN IN EXTREMITY (Pain on the arm of the vaccination) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       treatment medications were not reported no concomitant medications were reported  for mRNA-1273 (Moderna COVID-19 Vaccine) (intramuscular), the reporter did not provide any causality assessment.     Most recent FOLLOW-UP information incorporated above includes: On 12-Jul-2021: Follow-up received on 12-jul-2021contains no significant information
Fever, High white blood cell count, diverticulitis w/colon perforation, sepsis, adrenal hemorrage, shock, pulomnary embolism.
one woman had diarrhea for 3 days; This is a spontaneous report received from a contactable consumer reported for female (patient). A female patient of unspecified age received unknown dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection), via an unspecified route on an unspecified date as a single dose for covid-19 immunization. The patient medical history and concomitant medications were not reported. Reporter states that she lives in a retirement community and that COVID 19 had affected people who live there who have been fully vaccinated. She relayed that one woman had diarrhea for 3 days which she states can be very dangerous because it can lead to dehydration. Reporter wanted to know when would the booster dose be available and is it the same as the first two doses or different? She thinks you all do a great job. Thank you you're so articulate and knowledgeable, she appreciates it. She was very grateful recipient of the Pfizer COVID 19 vaccine and really feel like she owes her life to Pfizer for this vaccine. She asked is the vaccine effective against the delta and delta plus variant? Do you have any information on the Lambda variant? The clinical outcome of diarrhoea was recovered in 2021.  Follow-up attempts are completed. No further information is expected.
SkinRash, Rash, UrticariaPruritus,  ITCHing, hives, rash, 3 inches in diameter in upper arm  Narrative:
intense headache; This is a spontaneous report received from contactable reporter(s) (Nurse). The reporter is the patient.  A 74-year-old female patient received BNT162b2 (BNT162B2), on 11Feb2021 as dose 1, single (Lot number: EL9262) at the age of 73 years for covid-19 immunisation. The patient's relevant medical history included: "Osteoarthritis" (unspecified if ongoing), notes: Osteoarthritis; "Hypertension" (unspecified if ongoing), notes: Hypertension; "Eczema" (unspecified if ongoing), notes: Eczema; "arthritis" (unspecified if ongoing); "EGR Reflux" (unspecified if ongoing); "heartburn" (unspecified if ongoing); "acidity" (unspecified if ongoing); "gas pain" (unspecified if ongoing). Concomitant medication(s) included: CELEBREX taken for arthritis; CENTRUM [ASCORBIC ACID;BETACAROTENE;BIOTIN;CALCIUM;CHLORINE;CHROMIUM;COPPER;CYANOCOBALAMIN;DL-ALPHA TOCOPHERYL ACETATE;FOLIC ACID;IODINE;IRON;MAGNESIUM;MANGANESE;MOLYBDENUM;NICKEL;NICOTINAMIDE;PANTOTHENIC ACID;PHOSPHORUS;PHYTOMENADIONE;POTASSIUM;PYRI; LOSARTAN; HYDROCHLOROTHIAZIDE; PROTEX [ETHINYLESTRADIOL;MEDROXYPROGESTERONE ACETATE]; SIMETHICONE taken for flatulence; ALLEGRA taken for eczema; DEXILANT SOLUTAB taken for dyspepsia, gastric disorder. The following information was reported: HEADACHE (non-serious), outcome "unknown", described as "intense headache". Relevant laboratory tests and procedures are available in the appropriate section.
Severe aches and pains in muscles and joints; three days after second dose these symptoms persisted with burning sensation in lower abdomen and numbness/limpness in right leg; could not move right leg and had tingling sensation when touched on right calf/thigh.
Shingles. Low rapid breathing, heart racing. Entire left side went numb and was tingly only lasted 20 minutes.
Information has been received from a physician concerning a 18 year old male who on 07-JUN-1994 and 14-OCT-1994 was vaccinated with the first and second dose of MMR II (LOT # not reported). On 04-DEC-2009 the patient experienced mumps. On 11-NOV-2009, the patient was diagnosed with mumps. The patient was afebrile. The blood work was done on 11-NOV-2009 and the result was not reported. The patient's outcome was unknown, this case was non-serious.  Follow-up information has been received from a physician concerning a 18 year old male who on 07-JUN-1994 and 14-OCT-1994 was vaccianted with the first and second dose of MMR II (LOT# not reported). The physician reported that on 11-NOV-2009 the patient was diagnosed with mumps. The patient was afebrile and had a left side parotitis. At the time of the report, the patient's outcome was unknown. Additional information has been requested.
Sore throat, headache, body aches, fatigue, cough, dizziness, Fever and nausea. Still ongoing. Went to clinic to get COVID tested it was negative. Seen by a nurse practitioner, gave him meds for cough and nausea. Still hasn't resolved 7 days later.
Breakthrough COVID-19 case with unknown symptom status. Hospitalized 8/9/2021-8/15/2021. Death 8/15/2021. From Vital Records COD = CARDIOPULMONARY ARREST, ACUTE RESPIRATORY FAILURE, ACUTE CARDIAC FAILURE. Per vital records, COD ICD Codes include: Not yet coded ; Other Significant Conditions include: None listed. place of death: HOSPITAL-INPATIENT, MEDICAL CENTER; certified by PRONOUNCING AND CERTIFYING PHYSICIAN, occ/ind: RETAIL SALES, SALES
ERYTHEMA & INDURATION 30 X 30 MM OVER R-ARM (PCV7) - NO TREATMENT EXCEPT FOR WARM COMPRESS
COVID 19 Treatment; COVID 19 Treatment; This is a spontaneous report received from a contactable reporter(s) (Nurse). The reporter is the patient.  A 26-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 20May2022 at 19:00 as dose 4 (booster), single (Batch/Lot number: unknown) at the age of 26 years, in left arm for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown), as dose 2, single (Batch/Lot number: unknown) and as dose 3 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "Factor 5" (unspecified if ongoing), notes: other medical history: Factor 5. Concomitant medication(s) included: PROGESTERONE; BIOTIN; COLLAGEN. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset May2022, outcome "not recovered" and all described as "COVID 19 Treatment". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: Unknown Result. Therapeutic measures were taken as a result of drug ineffective, covid-19.  Clinical course: Anti Viral Details:  Product: COVID 19 Treatment Brand: Paxlovid: Treatment start date: 24May2022. Treatment stop date: 28May2022. Indication: Treatment of COVID-19. No allergies  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.; Sender's Comments: The reported COVID-19 positive after both the doses of COVID-19 immunization is considered ineffective of BNT162B2, and the Company cannot completely exclude the possible causality between the reported events and BNT162B2 administration.
Constant and nonstop coughing and runny nose. Headaches, tired some,
I had sore throat and a cough. On April 3rd, I was tested positive for COVID-19. On April 5th, the sore throat was so bad. I went to urgent care. They prescribed me steroid medicine. After that it went away.
Very high fever, rash, bronchitis, pharyngitis, rhinorrhea, headache, severe vomiting, coughing, wheezing, difficulty breathing, tachycardia, chest pain, conjunctivitis, congestion. He developed these symptoms within a 2 days of being vaccinated and various symptoms continued for 2 months.
Anxiety; not feeling well in my head; tiredness; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 68 year-old male patient received bnt162b2 (BNT162B2), administered in arm left, administration date 02Oct2021 13:00 (Batch/Lot number: unknown) at the age of 68 years as dose 1, single, administered in arm left (Batch/Lot number: unknown) as dose 2, single and (Lot number: 111) as dose 3 (booster), single for covid-19 immunisation. Relevant medical history included: "Neuropathy" (unspecified if ongoing). Concomitant medication(s) included: MORPHINE; ATIVAN; GABAPENTIN. Past drug history included: Cipro for Known allergies : cipro.  The following information was reported: ANXIETY (non-serious) with onset 22Oct2021 15:00, outcome "not recovered", described as "Anxiety"; HEAD DISCOMFORT (non-serious) with onset 22Oct2021 15:00, outcome "not recovered", described as "not feeling well in my head"; FATIGUE (non-serious) with onset 22Oct2021 15:00, outcome "not recovered", described as "tiredness". The events "anxiety", "not feeling well in my head" and "tiredness" were evaluated at the physician office visit. It was unknown if therapeutic measures were taken as a result of anxiety, head discomfort, fatigue.  Additional information: Patient did not receive any other vaccines within 4 weeks. Patient did not receive any vaccine prior to COVID-19 vaccination and had not been tested since post vaccination. Facility where the most recent COVID-19 vaccine was administered reported as Pharmacy or Drug Store.   No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Pt recvd vax & exp a seizure @ work & another seizure later that day @ hosp; admitted for 1-2 days;
18 mo well child visit PCV 13 inj (R) anterior lateral thigh 5cm X 7cm erythema, warm extended 1 cc beyond circle area drawn prev. noc. Symptoms started 5/24/10 in evening. Rx KEFLEX TID x 10days.
Vaccine was administered past the 10  week beyond use date of 07/05/23 - no adverse events reported
Left arm with significant redness and swelling around middle area of deltoid muscle. Slight redness noted at top area of clavicle bone on Left shoulder. Pt noted swollen lymph nodes in axillary area on Left arm. C/o pain by child. No LROM reported by child.
At the beginning of August I developed a cough, headache, and a bit of nasal congestion. I was on vacation, and when I returned home I received a covid19 test, on Aug 6th, which was negative.  I went into urgent care of Aug 7th due to difficulty breathing with sickness and my asthma. The nurse practioner diagnosed me with bronchitis. I was put on Prednisone for 4 days and issued an inhaler (my inhaler was expired and hadn't been used for years).I again went in on Aug 13th, and the bronchitis continued. They put me on a decreasing dose of prednisone, an antibiotic, and some coughing medication. I last went in on Aug 30th, where I had a chest xray due to having some blood in my coughed up mucus for a short time after waking  up on 8/30/21. Chest xray came back good, and that the bronchitis continues, but no longer hindering everyday activities. I DO NOT BELIEVE THIS IS DUE TO MY VACCINE. We have had unusual drought and fires where I reside that have impacted our air quality not like I've ever seen. For about a month before this, we have had off an on issues with air quality. My asthma, and a cold from my 3 year old son, I believe triggered this issue. He had a cough, that was gone after about a week.